These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015. Tang L; Zhou Y; Pan Y; Zhu H Vaccine; 2017 May; 35(22):2925-2929. PubMed ID: 28433329 [TBL] [Abstract][Full Text] [Related]
43. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Carrillo-Santisteve P; Lopalco PL Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():50-6. PubMed ID: 23051058 [TBL] [Abstract][Full Text] [Related]
44. Molecular epidemiology of measles virus in Taiwan in 2010-2011: the common genotype changed from H1 to D9 and the first appearance of D4. Cheng WY; Tung HP; Wang HC; Lee LL; Wu HS; Liu MT J Med Virol; 2013 Jun; 85(6):1095-9. PubMed ID: 23588738 [TBL] [Abstract][Full Text] [Related]
45. Population immunity to measles in the United States, 1999. Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096 [TBL] [Abstract][Full Text] [Related]
46. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children. Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235 [TBL] [Abstract][Full Text] [Related]
52. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207 [TBL] [Abstract][Full Text] [Related]
53. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751 [TBL] [Abstract][Full Text] [Related]
54. Evaluation on the effectiveness of the national childhood immunisation programme in Singapore, 1982-2007. Liew F; Ang LW; Cutter J; James L; Goh KT Ann Acad Med Singap; 2010 Jul; 39(7):532-10. PubMed ID: 20697671 [TBL] [Abstract][Full Text] [Related]
55. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China. Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146 [TBL] [Abstract][Full Text] [Related]
59. Epidemiologic and laboratory surveillance of the measles outbreak in the Federation of Bosnia and Herzegovina, February 2014-April 2015. Salimović-Bešić I; Šeremet M; Hübschen JM; Hukić M; Tihić N; Ahmetagić S; Delibegović Z; Pilav A; Mulaomerović M; Ravlija J; Muller CP; Dedeić-Ljubović A Clin Microbiol Infect; 2016 Jun; 22(6):563.e1-7. PubMed ID: 26928202 [TBL] [Abstract][Full Text] [Related]
60. Interruption of measles transmission in Gipuzkoa (Basque Country), Spain. Cilla G; Basterretxea M; Artieda J; Vicente D; Pérez-Trallero E Euro Surveill; 2004 May; 9(5):29-31. PubMed ID: 15208472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]